Gramantieri et al. reported that TP53 decreased the expression of miR-30e-3p in HCC and miR-30e-3p inhibited cell proliferation and invasion of HCC by targeting MDM2, PTEN and CDKN1B/p27 [61]. Here, MDM2 is linked to hepatocellular carcinoma.